AstraZeneca plc (GB:AZN) has released an update.
AstraZeneca PLC has announced that CEO Pascal Soriot was awarded 29,474 ordinary shares at £100.81 each, as part of the AstraZeneca Performance Share Plan (AZPSP). The award, tied to a mix of scientific, commercial, financial, and sustainability goals, will be vested over a three-year period, with an additional two-year holding period. This move aligns executive compensation with the company’s long-term performance and shareholder interests.
For further insights into GB:AZN stock, check out TipRanks’ Stock Analysis page.
